Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma

NCT00264849 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

406

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Omalizumab
OTHER: Optimized asthma therapy

Sponsor

Novartis

Collaborators

[object Object]
[object Object]